Your browser doesn't support javascript.
loading
TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of ß-catenin.
Ren, Huayan; Mi, Xiaoyi; Zhao, Pengyuan; Zhao, Xueyan; Wei, Na; Huang, Huifen; Meng, Zhongqin; Kou, Junna; Sun, Mingfang; Liu, Yuqiong; Zhang, Hongyan; Yang, Jianping; Li, Wencai; Li, Huixiang.
Affiliation
  • Ren H; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Mi X; College of Basic Medical Sciences, Zhengzhou University, Jianshe Road 1, Erqi Ward, Zhengzhou, 450052, P.R. China.
  • Zhao P; Department of Pathology, College of Basic Medical Sciences and First Affiliated Hospital, China Medical University, Shenyang, China.
  • Zhao X; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wei N; College of Basic Medical Sciences, Zhengzhou University, Jianshe Road 1, Erqi Ward, Zhengzhou, 450052, P.R. China.
  • Huang H; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Meng Z; College of Basic Medical Sciences, Zhengzhou University, Jianshe Road 1, Erqi Ward, Zhengzhou, 450052, P.R. China.
  • Kou J; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Sun M; College of Basic Medical Sciences, Zhengzhou University, Jianshe Road 1, Erqi Ward, Zhengzhou, 450052, P.R. China.
  • Liu Y; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang H; College of Basic Medical Sciences, Zhengzhou University, Jianshe Road 1, Erqi Ward, Zhengzhou, 450052, P.R. China.
  • Yang J; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li W; College of Basic Medical Sciences, Zhengzhou University, Jianshe Road 1, Erqi Ward, Zhengzhou, 450052, P.R. China.
  • Li H; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Breast Cancer Res Treat ; 183(2): 275-289, 2020 Sep.
Article in En | MEDLINE | ID: mdl-32671611
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Nuclear Proteins / Drug Resistance, Neoplasm / Ubiquitin-Protein Ligases / Beta Catenin / Etoposide / TNF Receptor-Associated Factor 4 Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Nuclear Proteins / Drug Resistance, Neoplasm / Ubiquitin-Protein Ligases / Beta Catenin / Etoposide / TNF Receptor-Associated Factor 4 Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: Country of publication: